Indian doctors warned of new superbug before Lancet study

August 13, 2010 by Phil Hazlewood

Indian doctors warned earlier this year about the threat from a new multi-drug resistant "superbug" -- months before a British study that New Delhi has condemned for scaremongering.

A team of researchers from a leading private hospital in Mumbai came to similar conclusions as the British study, which warned that foreigners coming to India for cut-price treatment could pick up NDM-1 and spread it worldwide.

India's health ministry angrily dismissed the claim in the medical journal The Lancet as exaggerated and unfair, while some politicians saw it as a conspiracy designed to scupper the country's booming health .

But Indian researchers themselves had said in March that they found 22 incidences of "New Delhi metallo-lactamase-1" producing bacteria in 24 infection cases between August and November last year.

"This high number in a relatively short span is a worrisome trend," the team from the Hinduja hospital said in the Journal of the Association of Physicians of India.

Equally worrying is the fact that NDM-1-carrying bacteria are resistant even to carbapenems, a group of antibiotics often reserved as a last resort for emergency treatment for multi-drug resistant bugs.

"The growing incidence and also the diversity of carbapenemase-producing strains is therefore of major concern," the researchers added, warning that the superbug "has the potential for further dissemination in the community".

The Indian team said they did not know the exact prevalence of NDM-1 but added that its spread "may endanger patients undergoing major treatment at centres in India and this may have adverse implications for medical tourism".

An Australian infectious diseases specialist on Friday said three people who had travelled to India for treatment had contracted the infection and the cases could be just the "tip of the iceberg", amid concern about its global spread.

Dr K. Abdul Gharfur, a consultant on in the southern city of Chennai, has said that the Indian medical authorities are in denial about the extent of multi-drug resistant infections.

He told AFP on Friday that no country was immune to the problem but it was likely to be more acute in places like India because of a lack of effective controls on the prescription of antibiotics.

"This bacteria, NDM-1, is increasing. It's true it's spreading in India. I'm sure it exists in almost every major hospital in India. But we have limited data," he said.

Few hospitals, including in the private sector, have specialist infection control departments and there was a general lack of awareness among doctors about the spread of drug-resistant infections, he added.

"The responsible authorities should only allow the use of antibiotics by qualified people" and proper monitoring of infections be carried out, as antibiotic-resistant infections are increasing, he said.

Related Stories

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Aug 14, 2010
Doctors in India generally dream to set up their own clinics. They are often from established doctor family feuds. Medical care is a huge business in India. Doctors often prescribe unnecessary medicines to patients especially excessive antibiotics. It is true that they lack awareness on the drug resistance bacteria. It is surprising to know that in india doctors do not follow research trends nor they do any research. So obviously they dont know. All they know is to what pill to give for hypertension and what pill for something else. if a patient has mixed symptoms they just give medicines for all those symptoms irrespective of whether the medicine conflict. Government hospitals in india are even more pathetic with patients awaiting for the doctor and with little care on critical hygene. So what more do you expect from such a system ? where medical science had become a business !!!
not rated yet Aug 14, 2010
Just to add, recently medical council of india (MCI), was abolished on high level corruption charges.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.